Phreesia, Inc. (NYSE:PHR) COO Sells $38,758.29 in Stock

Phreesia, Inc. (NYSE:PHR) COO Evan Roberts sold 1,843 shares of Phreesia stock in a transaction dated Tuesday, October 15th. The stock was sold at an average price of $21.03, for a total value of $38,758.29. Following the completion of the sale, the chief operating officer now directly owns 753,876 shares of the company’s stock, valued at approximately $15,854,012.28. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website.

Evan Roberts also recently made the following trade(s):

• On Tuesday, September 10th, Evan Roberts sold 3,148 shares of Phreesia stock. The stock was sold at an average price of $23.25, for a total transaction of $73,191.00.

Phreesia Trading Down 2.9 %

Phreesia stock opened at $19.80 on Friday. The stock has a 50-day moving average price of $23.30 and a 200 day moving average price of $22.41. The company has a market capitalization of $1.14 billion, a price-to-earnings ratio of -11.00 and a beta of 0.93. Phreesia, Inc. has a 52 week low of $12.05 and a 52 week high of $29.16. The company has a quick ratio of 1.77, a current ratio of 1.77 and a debt-to-equity ratio of 0.03.

Phreesia (NYSE:PHR) last posted its quarterly earnings data on Wednesday, September 4th. The company reported ($0.31) EPS for the quarter, topping the consensus estimate of ($0.37) by $0.06. The company had revenue of $102.12 million during the quarter, compared to analyst estimates of $101.76 million. Phreesia had a negative return on equity of 39.34% and a negative net margin of 25.73%. Sell-side analysts anticipate that Phreesia, Inc. will post -1.23 EPS for the current year.

Analyst Ratings Changes

A number of analysts recently weighed in on the company. Canaccord Genuity Group restated a “buy” rating and issued a $34.00 target price on shares of Phreesia in a research report on Thursday, September 5th. KeyCorp reduced their price target on shares of Phreesia from $27.00 to $25.00 and set an “overweight” rating on the stock in a research report on Thursday, July 11th. DA Davidson reaffirmed a “buy” rating and issued a $32.00 target price on shares of Phreesia in a research report on Thursday, September 5th. Needham & Company LLC restated a “buy” rating and issued a $29.00 price objective on shares of Phreesia in a report on Thursday, September 5th. Finally, Robert W. Baird upped their price target on Phreesia from $31.00 to $34.00 and gave the stock an “outperform” rating in a research note on Friday, September 6th. One research analyst has rated the stock with a hold rating and eleven have assigned a buy rating to the stock. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average target price of $29.42.

Institutional Inflows and Outflows

Institutional investors have recently bought and sold shares of the business. Vanguard Group Inc. boosted its position in shares of Phreesia by 4.4% during the 4th quarter. Vanguard Group Inc. now owns 4,628,441 shares of the company’s stock valued at $107,148,000 after acquiring an additional 194,035 shares during the last quarter. WoodTrust Financial Corp boosted its holdings in Phreesia by 87.9% in the 1st quarter. WoodTrust Financial Corp now owns 31,000 shares of the company’s stock valued at $742,000 after purchasing an additional 14,500 shares during the last quarter. Diversified Trust Co purchased a new stake in shares of Phreesia in the 1st quarter valued at approximately $256,000. Mirae Asset Global Investments Co. Ltd. increased its holdings in shares of Phreesia by 31.7% during the 1st quarter. Mirae Asset Global Investments Co. Ltd. now owns 132,581 shares of the company’s stock worth $3,173,000 after buying an additional 31,925 shares during the last quarter. Finally, Essex Investment Management Co. LLC increased its holdings in shares of Phreesia by 1.9% during the 1st quarter. Essex Investment Management Co. LLC now owns 59,764 shares of the company’s stock worth $1,430,000 after buying an additional 1,102 shares during the last quarter. 92.10% of the stock is owned by hedge funds and other institutional investors.

About Phreesia

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.